US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US20080075781A1
(en)
*
|
1992-11-25 |
2008-03-27 |
Purdue Pharma Lp |
Controlled release oxycodone compositions
|
IL109460A
(en)
|
1993-05-10 |
1998-03-10 |
Euro Celtique Sa |
Controlled release formulation comprising tramadol
|
US20070275062A1
(en)
*
|
1993-06-18 |
2007-11-29 |
Benjamin Oshlack |
Controlled release oxycodone compositions
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
KR100354702B1
(ko)
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
US5891471A
(en)
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
US5843480A
(en)
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
GB9422154D0
(en)
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
DE19530575A1
(de)
*
|
1995-08-19 |
1997-02-20 |
Gruenenthal Gmbh |
Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
DE69722191T2
(de)
*
|
1996-03-08 |
2004-04-01 |
Nycomed Danmark Aps |
Dosiszusammensetzung mit modifizierter freigabe aus vielen einzelkomponenten
|
DE19712398A1
(de)
*
|
1997-03-25 |
1998-10-01 |
Gruenenthal Gmbh |
Orale Anwendung von (+)-0-Demethyltramadol als Schmerzmittel
|
CA2270975C
(en)
*
|
1997-07-02 |
2003-04-01 |
Euro-Celtique, S.A. |
Stabilized sustained release tramadol formulations
|
US6156342A
(en)
*
|
1998-05-26 |
2000-12-05 |
Andex Pharmaceuticals, Inc. |
Controlled release oral dosage form
|
DE29818454U1
(de)
*
|
1998-10-15 |
1999-01-14 |
Euroceltique S.A., Luxemburg/Luxembourg |
Opioid-Analgetikum
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
AU3469100A
(en)
*
|
1999-01-05 |
2000-07-24 |
Copley Pharmaceutical Inc. |
Sustained release formulation with reduced moisture sensitivity
|
DE19901692C2
(de)
*
|
1999-01-18 |
2002-06-20 |
Gruenenthal Gmbh |
Verfahren zur Herstellung von Pellets mit einem Gehalt von bis zu 90 Gew.% eines pharmazeutischen Wirkstoffes
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
BR0013825A
(pt)
*
|
1999-08-31 |
2002-07-23 |
Gruenenthal Chemie |
Formas de apresentação de tramadol
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
BRPI0015284B8
(pt)
|
1999-10-29 |
2021-05-25 |
Euro Celtique S/A |
formulações de hidrocodona de liberação controlada
|
SK285128B6
(sk)
*
|
1999-12-28 |
2006-07-07 |
Zentiva, A. S. |
Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy
|
ES2228789T3
(es)
*
|
2000-09-22 |
2005-04-16 |
Smb Technology |
Composicion oral de tramadol en forma de granulados para tomar una vez por dia.
|
KR101045144B1
(ko)
|
2000-10-30 |
2011-06-30 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
DE10108122A1
(de)
|
2001-02-21 |
2002-10-02 |
Gruenenthal Gmbh |
Arzneimittel auf Basis von Tramadol
|
DE60211689T2
(de)
|
2001-03-16 |
2007-01-11 |
DMI Biosciences, Inc., Englewood |
Verwendung von Tramadol zur Verzögerung der Ejakulation
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
PE20030527A1
(es)
*
|
2001-10-24 |
2003-07-26 |
Gruenenthal Chemie |
Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
|
US20060099249A1
(en)
*
|
2002-02-21 |
2006-05-11 |
Pawan Seth |
Modified release formulations of at least one form of tramadol
|
US8128957B1
(en)
*
|
2002-02-21 |
2012-03-06 |
Valeant International (Barbados) Srl |
Modified release compositions of at least one form of tramadol
|
AU2003225837B2
(en)
*
|
2002-03-15 |
2008-11-06 |
Forest Laboratories Holdings Limited |
NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
|
CN1642532A
(zh)
*
|
2002-03-22 |
2005-07-20 |
西拉格股份公司 |
曲马多缓释制剂
|
DE10224108A1
(de)
*
|
2002-05-29 |
2004-01-29 |
Grünenthal GmbH |
1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung
|
US7410965B2
(en)
|
2002-05-29 |
2008-08-12 |
Gruenenthal Gmbh |
Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
US20050020613A1
(en)
*
|
2002-09-20 |
2005-01-27 |
Alpharma, Inc. |
Sustained release opioid formulations and method of use
|
US8487002B2
(en)
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
US20060003004A1
(en)
*
|
2002-10-25 |
2006-01-05 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
TWI319713B
(en)
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
US20040121010A1
(en)
*
|
2002-10-25 |
2004-06-24 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
AU2004207578B2
(en)
*
|
2003-01-28 |
2007-06-28 |
Collegium Pharmaceutical, Inc. |
Multiparticulate compositions of milnacipran for oral administration
|
DE10333835A1
(de)
*
|
2003-07-24 |
2005-03-10 |
Gruenenthal Gmbh |
6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol enthaltendes Arzneimittel mit verzögerter Wirkstofffreisetzung
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
ES2407143T3
(es)
*
|
2003-08-06 |
2013-06-11 |
Grünenthal GmbH |
Forma de dosificación protegida contra un posible abuso
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US8075872B2
(en)
*
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
DE102005005446A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
DE102004032051A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
US20070048228A1
(en)
*
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
US20050089558A1
(en)
*
|
2003-10-28 |
2005-04-28 |
Alamo Pharmaceuticals, Llc |
Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
|
DE102004032103A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
EP1917000A2
(en)
*
|
2005-07-07 |
2008-05-07 |
Farnam Companies, Inc. |
Sustained release pharmaceutical compositions for highly water soluble drugs
|
ES2389666T3
(es)
|
2005-09-09 |
2012-10-30 |
Angelini Labopharm, Llc |
Composición de trazodona para una administración de una vez al día
|
US20090104266A1
(en)
*
|
2005-09-15 |
2009-04-23 |
Tobias Jung |
3-(2-dimethylaminomethylcy clohexyl)phenol retard formulation
|
US8691272B2
(en)
*
|
2005-12-30 |
2014-04-08 |
Intelgenx Corp. |
Multilayer tablet
|
US20070190141A1
(en)
*
|
2006-02-16 |
2007-08-16 |
Aaron Dely |
Extended release opiate composition
|
CA2671197A1
(en)
*
|
2006-07-21 |
2008-01-24 |
Lab International Srl |
Hydrophobic abuse deterrent delivery system
|
DE102006044694A1
(de)
*
|
2006-09-22 |
2008-03-27 |
Krewel Meuselbach Gmbh |
Perorale feste Schmerzmittelzubereitung
|
PL2120570T3
(pl)
*
|
2007-02-12 |
2012-10-31 |
Vyrix Pharmaceuticals Inc |
Leczenie współwystępującego przedwczesnego wytrysku i zaburzenia wzwodu prącia
|
CA2677691C
(en)
|
2007-02-12 |
2012-07-31 |
David Bar-Or |
Reducing side effects of tramadol
|
DE102007011485A1
(de)
*
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
MX336494B
(es)
*
|
2007-10-16 |
2016-01-21 |
Paladin Labs Inc |
Composicion de bicapas para la liberacion controlada de acetaminofeno y tramadol.
|
KR20100121463A
(ko)
|
2007-12-17 |
2010-11-17 |
라보팜 인코포레이트 |
오용 예방적 방출 제어형 제제
|
BRPI0906467C1
(pt)
*
|
2008-01-25 |
2021-05-25 |
Gruenenthal Gmbh |
forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
|
LT2273983T
(lt)
*
|
2008-05-09 |
2016-10-25 |
Grünenthal GmbH |
Tarpinės miltelių kompozicijos gamybos būdas ir galutinė kieta dozavimo forma naudojant purškalo kietinimo stadija
|
US20100003322A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Lai Felix S |
Enteric coated hydrophobic matrix formulation
|
ES2509497T3
(es)
*
|
2008-12-16 |
2014-10-17 |
Paladin Labs Inc. |
Formulación de liberación controlada para evitar un uso indebido
|
KR101747156B1
(ko)
|
2009-07-22 |
2017-06-27 |
그뤼넨탈 게엠베하 |
산화-안정화된 탬퍼-내성 용량형
|
TW201105316A
(en)
|
2009-07-22 |
2011-02-16 |
Gruenenthal Gmbh |
Hot-melt extruded pharmaceutical dosage form
|
US10610528B2
(en)
|
2009-12-08 |
2020-04-07 |
Intelgenx Corp. |
Solid oral film dosage forms and methods for making same
|
US20110136815A1
(en)
|
2009-12-08 |
2011-06-09 |
Horst Zerbe |
Solid oral film dosage forms and methods for making same
|
CN102821757B
(zh)
*
|
2010-02-03 |
2016-01-20 |
格吕伦塔尔有限公司 |
通过挤出机制备粉末状药物组合物
|
US9993433B2
(en)
|
2010-05-10 |
2018-06-12 |
Euro-Celtique S.A. |
Manufacturing of active-free granules and tablets comprising the same
|
AR082189A1
(es)
|
2010-07-06 |
2012-11-21 |
Gruenenthal Gmbh |
Formas de dosificacion gastrorretentivas, procedimiento
|
RU2607499C2
(ru)
|
2010-09-02 |
2017-01-10 |
Грюненталь Гмбх |
Устойчивая к разрушению лекарственная форма, которая содержит анионный полимер
|
MX2013002377A
(es)
|
2010-09-02 |
2013-04-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
|
WO2012061779A1
(en)
*
|
2010-11-04 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Drug formulations
|
EA201400173A1
(ru)
|
2011-07-29 |
2014-06-30 |
Грюненталь Гмбх |
Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
|
EA201400172A1
(ru)
|
2011-07-29 |
2014-06-30 |
Грюненталь Гмбх |
Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
|
JP6117249B2
(ja)
|
2012-02-28 |
2017-04-19 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
|
JP6282261B2
(ja)
|
2012-04-18 |
2018-02-21 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
不正使用防止および過量放出防止医薬剤形
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
AU2014273227B2
(en)
|
2013-05-29 |
2019-08-15 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing one or more particles
|
AR096439A1
(es)
|
2013-05-29 |
2015-12-30 |
Gruenenthal Gmbh |
Forma de dosificación resistente al uso indebido que contiene una o más partículas
|
CA2917136C
(en)
|
2013-07-12 |
2022-05-31 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
|
JP6480936B2
(ja)
|
2013-11-26 |
2019-03-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
クライオミリングによる粉末状医薬組成物の調製
|
AU2015261060A1
(en)
|
2014-05-12 |
2016-11-03 |
Grunenthal Gmbh |
Tamper resistant immediate release capsule formulation comprising Tapentadol
|
EA201692388A1
(ru)
|
2014-05-26 |
2017-05-31 |
Грюненталь Гмбх |
Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
|
MX2017013637A
(es)
|
2015-04-24 |
2018-03-08 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
|
CA2998259A1
(en)
|
2015-09-10 |
2017-03-16 |
Grunenthal Gmbh |
Protecting oral overdose with abuse deterrent immediate release formulations
|